Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:A06AX17
|
| gptkbp:CASNumber |
179474-81-8
|
| gptkbp:chemicalFormula |
C18H26ClN3O3
|
| gptkbp:contraindication |
inflammatory bowel disease
intestinal perforation obstructive ileus |
| gptkbp:drugClass |
selective serotonin 5-HT4 receptor agonist
|
| gptkbp:genericName |
gptkb:prucalopride
|
| gptkbp:halfLife |
24 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Motegrity
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Shire
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain headache |
| gptkbp:usedFor |
chronic idiopathic constipation
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|